Vaneck Biotech ETF(BBH-Q)NASDAQ
Today's Change
Real-Time Last Update
After Hours Change
After Hours Last Update
Volume
Overview
Name
Fund Family
Underlying Index
Inception Date
Exchange
Description
The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. Expenses for BBH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.
Investment Information
Managed Assets, $K
Shares Outstanding, K
Asset Class
Sectors
ETFs - Biotech
60-Month Beta
Net Asset Value
Management Fee
Most Recent Dividend
Last Dividend Date
Dividend Yield
Has Options
20-Day Average Volume
52-Week RangeLow price148.52-High price183.64
YTD Return %
1-Year %Chg
3-Year %Chg
5-Year %Chg
